FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Vancomycin Hydrochloride Injection
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

Expand all

Hospira, Inc., a Pfizer Company (New 11/14/2025)

Company Contact Information:
844-646-4398

Presentation	Posting Date	Related Information
Vancomycin Hydrochloride, Injection, 750 mg Single Dose ADD-Vantage® Glass Vial (NDC 0409-6531-01)	09/09/2025	Discontinuation of the manufacture of the drug
Vancomycin Hydrochloride, Injection, 1 g Single Dose ADD-Vantage® Glass Vial (NDC 0409-6535-01)	09/09/2025	Discontinuation of the manufacture of the drug
Vancomycin Hydrochloride, Injection, 10 g Vial NovaPlus (NDC 0409-5017-01)	11/14/2025	Discontinuation of the manufacture of the drug